{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:31:17Z","timestamp":1785713477230,"version":"3.56.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010897","name":"Newton Fund","doi-asserted-by":"publisher","award":["172686537"],"award-info":[{"award-number":["172686537"]}],"id":[{"id":"10.13039\/100010897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011722","name":"Higher Education Funding Council for England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pneumococcal pneumonia is the leading cause of under-five mortality globally. The surveillance of pneumococcal serotypes is therefore vital for informing pneumococcal vaccination policy and programmes. Pneumococcal conjugate vaccines (PCVs) have been available as an option in the private healthcare setting and beginning December 2020, PCV10 was incorporated as part of routine national immunisation programme (NIP) in Malaysia. We searched existing literature on pneumococcal serotype distribution across Malaysia to provide an overall view of this distribution before the implementation of PCV10.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Online databases (PubMed, Ovid MEDLINE and Scopus), reference lists of articles identified, and grey literature (Malaysian Ministry of Health website, WHO website) were systematically searched for relevant literature on pneumococcal serotype distribution across Malaysia up to 10th November 2020. No lower date limit was set to maximise the number of target reports returned. Results of serotypes were split by age categories, including \u22645\u2009years, &gt;\u20095\u2009years and unreported for those that did not specify.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The search returned 18 relevant results, with a total of 2040 isolates. The most common serotypes across all disease types were 19F (<jats:italic>n<\/jats:italic>\u2009=\u2009313, 15.3% [95%CI: 13.8\u201317.0]), 23F (<jats:italic>n<\/jats:italic>\u2009=\u2009166, 8.1% [95%CI: 7.0\u20139.4]), 14 (n\u2009=\u2009166, 8.1% [95%CI: 7.0\u20139.4]), 6B (<jats:italic>n<\/jats:italic>\u2009=\u2009163, 8.0% [95%CI: 6.9\u20139.2]) and 19A (<jats:italic>n<\/jats:italic>\u2009=\u2009138, 6.8% [95%CI: 5.8\u20137.9]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Four of the most common serotypes across all isolate sources in Malaysia are covered by PCV10, while PCV13 provides greater serotype coverage in comparison to PCV10. There is still a need for surveillance studies, particularly those investigating serotypes in children under 5 years of age, to monitor vaccine effectiveness and pneumococcal population dynamic following implementation of PCV10 into routine immunisation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41479-021-00086-7","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T23:07:20Z","timestamp":1621897640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1146-9093","authenticated-orcid":false,"given":"Alex J. J.","family":"Lister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Foh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy Seong Guan","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Nasir Mohd","family":"Desa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"86_CR1","unstructured":"WHO, 2014. Pneumococcal Disease. [Online] Available at: https:\/\/www.who.int\/immunization\/diseases\/pneumococcal\/en\/ [Accessed 17 October 2020]."},{"key":"86_CR2","doi-asserted-by":"publisher","unstructured":"Ndlangisa K, du Plessis M, Allam M, Wolter N, de Gouveia L, Klugman KP, et al. Invasive disease caused simultaneously by dual serotypes of streptococcus pneumoniae. J Clin Microbiol. 2017;56(1). https:\/\/doi.org\/10.1128\/JCM.01149-17.","DOI":"10.1128\/JCM.01149-17"},{"key":"86_CR3","unstructured":"CDC, 2019. Pneumococcal disease. [Online] Available at: https:\/\/www.cdc.gov\/pneumococcal\/clinicians\/transmission.html [Accessed 17 October 2020]."},{"issue":"2","key":"86_CR4","doi-asserted-by":"publisher","first-page":"e0212295","DOI":"10.1371\/journal.pone.0212295","volume":"14","author":"J Ngocho","year":"2019","unstructured":"Ngocho J, et al. Effectiveness of pneumococcal conjugate vaccines against pneumococcal disease among children under five years of age in Africa: a systematic review. PLoS One. 2019;14(2):e0212295. https:\/\/doi.org\/10.1371\/journal.pone.0212295.","journal-title":"PLoS One"},{"issue":"2","key":"86_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.vaccine.2018.10.077","volume":"37","author":"C Satzke","year":"2019","unstructured":"Satzke C, Dunne EM, Choummanivong M, Ortika BD, Neal EFG, Pell CL, et al. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine. 2019;37(2):296\u2013305. https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.077.","journal-title":"Vaccine"},{"issue":"3","key":"86_CR6","doi-asserted-by":"publisher","first-page":"e00937","DOI":"10.1128\/mBio.00937-20","volume":"11","author":"F Ganaie","year":"2020","unstructured":"Ganaie F, Saad JS, McGee L, van Tonder AJ, Bentley SD, Lo SW, et al. A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus. mBio. 2020;11(3):e00937\u201320.","journal-title":"mBio"},{"key":"86_CR7","doi-asserted-by":"publisher","unstructured":"Shainheit M, Mule M, Camilli A. The Core promoter of the capsule operon of Streptococcus pneumoniae is necessary for colonization and invasive disease. Infect Immun. 2013;82(2):694\u2013705. https:\/\/doi.org\/10.1128\/IAI.01289-13.","DOI":"10.1128\/IAI.01289-13"},{"key":"86_CR8","unstructured":"Clinicaltrials.gov. Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. 2018. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00344318?recrs=e&rslt=With&cond=PCV10&rank=7&view=results. Accessed 22 Dec 2020."},{"key":"86_CR9","unstructured":"Clinicaltrials.gov. Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants. 2019. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=&type=&rslt=&age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=NCT03197376&cntry=&state=&city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort= Accessed 22 Dec 2020."},{"key":"86_CR10","unstructured":"PATH. Fact sheet: pneumococcal disease, pneumococcal conjugate vaccines, and PNEUMOSIL\u00ae. 2019. Available from: https:\/\/www.path.org\/resources\/fact-sheetpneumococcal-disease-pneumococcal-conjugate-vaccines-and-pneumosil\/. Accessed 17 Oct 2020."},{"issue":"45","key":"86_CR11","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1016\/j.vaccine.2018.02.113","volume":"36","author":"D Greenberg","year":"2018","unstructured":"Greenberg D, Hoover PA, Vesikari T, Peltier C, Hurley DC, McFetridge RD, et al. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Vaccine. 2018;36(45):6883\u201391. https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.113.","journal-title":"Vaccine."},{"key":"86_CR12","doi-asserted-by":"publisher","unstructured":"Hurley D, et al. Safety, tolerability, and immunogenicity of a 20-Valent pneumococcal conjugate vaccine (PCV20) in adults 60 to 64 years of age. Clin Infect Dis. 2020;ciaa1045:1\u20139.\u00a0https:\/\/doi.org\/10.1093\/cid\/ciaa1045.","DOI":"10.1093\/cid\/ciaa1045"},{"key":"86_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2018.12.009","volume":"80","author":"R Arushothy","year":"2019","unstructured":"Arushothy R, Ahmad N, Amran F, Hashim R, Samsudin N, Rosalina Che Azih C. Pneumococcal serotype distribution and antibiotic susceptibility in Malaysia: a four-year study (2014\u20132017) on invasive paediatric isolates. Int J Infect Dis. 2019;80:129\u201333.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"86_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1586\/eri.12.54","volume":"10","author":"CF Le","year":"2012","unstructured":"Le CF, Jefferies JM, Yusof MYM, Sekaran SD, Clarke SC. The epidemiology of pneumococcal carriage and infections in Malaysia. Expert Rev Anti-Infect Ther. 2012;10(6):707\u201319. https:\/\/doi.org\/10.1586\/eri.12.54.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"86_CR15","unstructured":"Linus-Lojikip S, Zulaikha F, Mohamed Nor J, Ahamad Romazul N, Hidayah Shamshuddin N, Ngah R, et al. Parents' knowledge on pneumococcal vaccine and opinions on payment strategies in Malaysia. Int J Stud Children Women Elderly Disabled. 2019;8:86-95."},{"issue":"24","key":"86_CR16","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1016\/j.vaccine.2012.03.066","volume":"30","author":"E Jauneikaite","year":"2012","unstructured":"Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine. 2012;30(24):3503\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.066.","journal-title":"Vaccine"},{"key":"86_CR17","unstructured":"GAVI.org. Eligibility. 2021. Available from: https:\/\/www.gavi.org\/types-support\/sustainability\/eligibility. Accessed 05 Jan 2021."},{"key":"86_CR18","doi-asserted-by":"publisher","unstructured":"Aljunid S, Abuduxike G, Ahmed Z, Sulong S, Muhd Nur A, Goh A. Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia. BMC Infect Dis. 2011;11(248):1-10. https:\/\/doi.org\/10.1186\/1471-2334-11-248.","DOI":"10.1186\/1471-2334-11-248"},{"issue":"35","key":"86_CR19","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.vaccine.2017.03.053","volume":"18","author":"S Tricarico","year":"2017","unstructured":"Tricarico S, McNeil HC, Head MG, Cleary DW, Clarke SC. Informing pneumococcal conjugate vaccine policy in middle income countries: the case of Malaysia. Vaccine. 2017;18(35):2288\u201390.","journal-title":"Vaccine"},{"issue":"1","key":"86_CR20","first-page":"25","volume":"15","author":"N Maimaiti","year":"2015","unstructured":"Maimaiti N, Lotfizadeh M, Ahmed Z, Rahimi A, Jadoo SA, Al JS. Incidence of pneumococcal meningitis in children less than 5 years of age in Malaysia, Singapore and Thailand: a review. Malays J Public Health Med. 2015;15(1):25\u20139.","journal-title":"Malays J Public Health Med"},{"issue":"4","key":"86_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/tropej\/34.4.182","volume":"34","author":"YM Cheong","year":"1988","unstructured":"Cheong YM, Jegathesan M, Henrichsen J, Wong YH, Ng AJ, Louis A. Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae in Malaysian children. J Trop Pediatr. 1988;34(4):182\u20135. https:\/\/doi.org\/10.1093\/tropej\/34.4.182.","journal-title":"J Trop Pediatr"},{"issue":"5\u20136","key":"86_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cimid.2014.10.005","volume":"37","author":"N Shakrin","year":"2014","unstructured":"Shakrin N, Masri S, Taib N, Nordin S, Jamal F, Desa M. Genotypic characterization of Malaysian human isolates of Streptococcus pneumoniae from carriage and clinical sources. Comp Immunol Microbiol Infect Dis. 2014;37(5\u20136):347\u201354. https:\/\/doi.org\/10.1016\/j.cimid.2014.10.005.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"86_CR23","doi-asserted-by":"crossref","unstructured":"Rohani M, Raudzah A, Ng A, Ng P, Zaidatul A, Asmah I, et al. Epidemiology of Streptococcus pneumoniae infection in Malaysia. Epidemiol Infect. 1999;122(1):77\u201382.","DOI":"10.1017\/S0950268898001605"},{"issue":"6","key":"86_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1086\/514783","volume":"28","author":"JH Song","year":"1999","unstructured":"Song JH, Lee NY, Ichiyama S, Yoshida R, Hirakata Y, Fu Y, et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian network for surveillance of resistant pathogens (ANSORP) study. Clin Infect Dis. 1999;28(6):1206\u201311. https:\/\/doi.org\/10.1086\/514783.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"86_CR25","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1086\/320165","volume":"32","author":"N Lee","year":"2001","unstructured":"Lee N, Song J, Kim S, Peck K, Ahn K, Lee S, et al. Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by the Asian network for surveillance of resistant pathogens (ANSORP). Clin Infect Dis. 2001;32(10):1463\u20139. https:\/\/doi.org\/10.1086\/320165.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"86_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1201-9712(03)90051-8","volume":"7","author":"M Desa","year":"2003","unstructured":"Desa M, Lin T, Yasin R, Parasakthi N. Penicillin susceptibility and molecular characteristics of clinical isolates of Streptococcus pneumoniae at the University of Malaya Medical Center, Kuala Lumpur. Malaysia International Journal of Infectious Diseases. 2003;7(3):190\u20137. https:\/\/doi.org\/10.1016\/S1201-9712(03)90051-8.","journal-title":"Malaysia International Journal of Infectious Diseases"},{"issue":"5","key":"86_CR27","doi-asserted-by":"publisher","first-page":"e19547","DOI":"10.1371\/journal.pone.0019547","volume":"6","author":"C Le","year":"2011","unstructured":"Le C, Palanisamy N, Mohd Yusof M, Sekaran S. Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia. PLoS One. 2011;6(5):e19547. https:\/\/doi.org\/10.1371\/journal.pone.0019547.","journal-title":"PLoS One"},{"issue":"6","key":"86_CR28","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1128\/AAC.48.6.2101-2107.2004","volume":"48","author":"J Song","year":"2004","unstructured":"Song J, Jung S, Ko KS, Kim NY, Son JS, Chang H, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004;48(6):2101\u20137. https:\/\/doi.org\/10.1128\/AAC.48.6.2101-2107.2004.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"86_CR29","doi-asserted-by":"publisher","first-page":"e97912","DOI":"10.1371\/journal.pone.0097912","volume":"9","author":"J Jefferies","year":"2003","unstructured":"Jefferies J, Mohd Yusof M, Devi Sekaran S, Clarke S. Novel clones of Streptococcus pneumoniae causing invasive disease in Malaysia. PLoS One. 2003;9(6):e97912.","journal-title":"PLoS One"},{"issue":"34","key":"86_CR30","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1016\/j.vaccine.2011.06.004","volume":"29","author":"M Rohani","year":"2011","unstructured":"Rohani M, Zin N, Hussin A, Nawi S, Hanapiah S, Wahab Z, et al. Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitals. Vaccine. 2011;29(34):5688\u201393. https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.004.","journal-title":"Vaccine."},{"issue":"3","key":"86_CR31","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1128\/AAC.05658-11","volume":"56","author":"SH Kim","year":"2012","unstructured":"Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian network for surveillance of resistant pathogens (ANSORP) study. Antimicrob Agents Chemother. 2012;56(3):1418\u201326. https:\/\/doi.org\/10.1128\/AAC.05658-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"86_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jmii.2012.04.004","volume":"46","author":"M Yatim","year":"2013","unstructured":"Yatim M, Masri S, Desa M, Taib N, Nordin S, Jamal F. Determination of phenotypes and pneumococcal surface protein a family types of Streptococcus pneumoniae from Malaysian healthy children. J Microbiol Immunol Infect. 2013;46(3):180\u20136. https:\/\/doi.org\/10.1016\/j.jmii.2012.04.004.","journal-title":"J Microbiol Immunol Infect"},{"issue":"38","key":"86_CR33","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1016\/j.vaccine.2019.09.065","volume":"38","author":"S Kim","year":"2020","unstructured":"Kim S, Chung D, Song J, Baek J, Thamlikitkul V, Wang H, et al. Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: emergence of drug resistance non-vaccine serotypes. Vaccine. 2020;38(38):6065\u201373. https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.065.","journal-title":"Vaccine"},{"issue":"2","key":"86_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/ijmr.IJMR_1987_16","volume":"148","author":"P Subramaniam","year":"2018","unstructured":"Subramaniam P, Jabar K, Kee B, Chong C, Nathan A, de Bruyne J, et al. Serotypes & penicillin susceptibility of Streptococcus pneumoniae isolated from children admitted to a tertiary teaching hospital in Malaysia. Indian J Med Res. 2018;148(2):225\u201331. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1987_16.","journal-title":"Indian J Med Res"},{"issue":"1","key":"86_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/20477724.2020.1719325","volume":"114","author":"SL Goh","year":"2020","unstructured":"Goh SL, Kee BP, Jabar KA, Chua KH, Nathan AM, Bruyne J, et al. Molecular detection and genotypic characterisation of Streptococcus pneumoniae isolated from children in Malaysia. Pathogens Glob Health. 2020;114(1):46\u201354. https:\/\/doi.org\/10.1080\/20477724.2020.1719325.","journal-title":"Pathogens Glob Health"},{"key":"86_CR36","doi-asserted-by":"crossref","unstructured":"Bahtar A, Abdul Manap R, Ban A. A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia. Eur Respir J. 2016;48.","DOI":"10.1183\/13993003.congress-2016.PA2591"},{"key":"86_CR37","doi-asserted-by":"publisher","unstructured":"Cleary D, Morris D, Anderson R, Jones J, Alattraqchi A, A. Rahman N et al. The upper respiratory tract microbiome of indigenous Orang Asli in north-eastern Peninsular Malaysia. Npj Biofilms Microbiomes. 2021;7(1):1-10. https:\/\/doi.org\/10.1038\/s41522-020-00173-5.","DOI":"10.1038\/s41522-020-00173-5"},{"issue":"6","key":"86_CR38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00006454-199506000-00007","volume":"14","author":"DH Sniadack","year":"1995","unstructured":"Sniadack DH, Schwartz B, Lipman J, Bogaerts J, Butler JC, Dagan R, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. Pediatr Infect Dis J. 1995;14(6):503\u201310. https:\/\/doi.org\/10.1097\/00006454-199506000-00007.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"86_CR39","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1086\/423820","volume":"190","author":"AB Brueggemann","year":"2004","unstructured":"Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the Serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis. 2004;190(7):1203\u201311. https:\/\/doi.org\/10.1086\/423820.","journal-title":"J Infect Dis"},{"issue":"5","key":"86_CR40","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.vaccine.2010.11.055","volume":"29","author":"R Kaur","year":"2011","unstructured":"Kaur R, Casey JR, Pichichero ME. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children. Vaccine. 2011;29(5):1023\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.055.","journal-title":"Vaccine."},{"key":"86_CR41","doi-asserted-by":"publisher","unstructured":"Clarke C, Bakaletz LO, Ruiz-Gui\u00f1az\u00fa J, Borys D, Mrkvan T. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage. Expert Rev Vaccines. 2017;16(7):1-14. https:\/\/doi.org\/10.1080\/14760584.2017.1333905.","DOI":"10.1080\/14760584.2017.1333905"},{"issue":"8","key":"86_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S2352-4642(18)30168-8","volume":"2","author":"M Pichichero","year":"2018","unstructured":"Pichichero M, Kaur R, Scott DA, Gruber WC, Trammel J, Almudevar A, et al. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study. Lancet Child Adolesc Health. 2018;2(8):561\u20138. https:\/\/doi.org\/10.1016\/S2352-4642(18)30168-8.","journal-title":"Lancet Child Adolesc Health"},{"key":"86_CR43","doi-asserted-by":"publisher","unstructured":"Cleary D, Devine V, Morris D, Osman K, Gladstone R, Bentley S, et al. Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae. Microbial Genomics. 2018;4(9):e000209. https:\/\/doi.org\/10.1099\/mgen.0.000209.","DOI":"10.1099\/mgen.0.000209"},{"key":"86_CR44","doi-asserted-by":"publisher","unstructured":"van den Bergh MR, Spijkerman J, Swinnen KM, Fran\u00e7ois NA, Pascal TG, Borys D, et al. Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D\u2013 conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis. 2012;56(3):e30\u20139. https:\/\/doi.org\/10.1093\/cid\/cis922.\u00a0","DOI":"10.1093\/cid\/cis922"},{"key":"86_CR45","doi-asserted-by":"publisher","unstructured":"Hausdorff WP, Hoet B, Schuerman L. Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A? BMC Pediatr. 2010;10(4):1-7. https:\/\/doi.org\/10.1186\/1471-2431-10-4.","DOI":"10.1186\/1471-2431-10-4"},{"issue":"3","key":"86_CR46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1128\/CVI.00344-08","volume":"16","author":"H Lee","year":"2009","unstructured":"Lee H, Nahm MH, Burton R, Kim KH. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Clin Vaccine Immunol. 2009;16(3):376\u201381. https:\/\/doi.org\/10.1128\/CVI.00344-08.","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"86_CR47","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1128\/IAI.71.5.2956-2959.2003","volume":"71","author":"H Jakobsen","year":"2003","unstructured":"Jakobsen H, Sigurdsson VD, Sigurdardottir S, Schulz D, Jonsdottir I. Pneumococcal serotype 19F conjugate vaccine induces cross-protective immunity to serotype 19A in a murine pneumococcal pneumonia model. Infect Immun. 2003;71(5):2956\u20139. https:\/\/doi.org\/10.1128\/IAI.71.5.2956-2959.2003.","journal-title":"Infect Immun"},{"key":"86_CR48","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1017\/S0950268819000013","volume":"147","author":"MP Mott","year":"2019","unstructured":"Mott MP, Caier\u00e3o J, Cunha GR, del Maschi MM, Pizzutti K, d\u2019Azevedo P, et al. Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with a ST320 in adult population, in Porto Alegre, Brazil. Epidemiol Infect. 2019;147:e93. https:\/\/doi.org\/10.1017\/S0950268819000013.","journal-title":"Epidemiol Infect"},{"key":"86_CR49","doi-asserted-by":"publisher","unstructured":"Tai SS. Streptococcus pneumoniae serotype distribution and pneumococcal conjugate vaccine serotype coverage among pediatric patients in east and Southeast Asia, 2000\u20132014: a pooled data analysis. Vaccines (Basel). 2016;4(1):1-15. https:\/\/doi.org\/10.3390\/vaccines4010004.","DOI":"10.3390\/vaccines4010004"},{"key":"86_CR50","doi-asserted-by":"publisher","unstructured":"Moreno GC, Imbachi LF, Leal AL, Moreno VM, Pati\u00f1o JA, Guti\u00e9rrez IF, et al. Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogot\u00e1, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10. Hum Vaccines Immunotherapeutics. 2020;16(9):2300-6. https:\/\/doi.org\/10.1080\/21645515.2019.1710411","DOI":"10.1080\/21645515.2019.1710411"},{"issue":"11","key":"86_CR51","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1086\/498043","volume":"192","author":"R Pai","year":"2005","unstructured":"Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B. Active bacterial Core surveillance team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis. 2005;192(11):1988\u201395. https:\/\/doi.org\/10.1086\/498043.","journal-title":"J Infect Dis"},{"key":"86_CR52","doi-asserted-by":"publisher","unstructured":"McIntosh EDG, Reinert RR. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev Vaccines. 2011;10(1):109-29. https:\/\/doi.org\/10.1586\/erv.10.145","DOI":"10.1586\/erv.10.145"},{"issue":"1","key":"86_CR53","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1128\/IAI.73.1.431-435.2005","volume":"73","author":"WP Hanage","year":"2005","unstructured":"Hanage WP, Kaijalainen TH, Syrj\u00e4nen RK, Auranen K, Leinonen M, M\u00e4kel\u00e4 PH, et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun. 2005;73(1):431\u20135. https:\/\/doi.org\/10.1128\/IAI.73.1.431-435.2005.","journal-title":"Infect Immun"},{"issue":"6","key":"86_CR54","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/14760584.2018.1413354","volume":"17","author":"P Izurieta","year":"2018","unstructured":"Izurieta P, Bahety P, Adegbola R, Clarke C, Hoet B. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Rev Vaccines. 2018;17(6):479\u201393. https:\/\/doi.org\/10.1080\/14760584.2018.1413354.","journal-title":"Expert Rev Vaccines"},{"key":"86_CR55","doi-asserted-by":"publisher","unstructured":"Habib M, Porter BD, Satzke C. Capsular serotyping of Streptococcus pneumoniae using the Quellung reaction. J Vis Exp. 2014;84:e51208. https:\/\/doi.org\/10.3791\/51208.","DOI":"10.3791\/51208"},{"issue":"1","key":"86_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/JCM.44.1.124-131.2006","volume":"44","author":"R Pai","year":"2006","unstructured":"Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44(1):124\u201331. https:\/\/doi.org\/10.1128\/JCM.44.1.124-131.2006.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"86_CR57","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/21505594.2017.1309492","volume":"8","author":"J Langereis","year":"2017","unstructured":"Langereis J. de Jonge. Non-encapsulated streptococcus pneumoniae, vaccination as a measure to interfere with horizontal gene transfer. Virulence. 2017;8(6):637\u20139. https:\/\/doi.org\/10.1080\/21505594.2017.1309492.","journal-title":"Virulence"},{"issue":"7","key":"86_CR58","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1080\/21645515.2019.1701911","volume":"16","author":"AA Shafie","year":"2020","unstructured":"Shafie AA, Ahmad N, Naidoo J, Yoong Foo C, Wong C, Pugh S, et al. Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia - an economic evaluation. Hum Vaccines Immunotherapeutics. 2020;16(7):1719\u201327. https:\/\/doi.org\/10.1080\/21645515.2019.1701911.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"86_CR59","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.vhri.2014.04.008","volume":"3","author":"S Aljunid","year":"2014","unstructured":"Aljunid S, Maimaiti N, Ahmed Z, Nur AM, Md Isa Z, Azmi A, et al. Economic impact of pneumococcal protein-D conjugate vaccine (PHiD-CV) on the Malaysian National Immunization Programme. Value Health Reg Issue. 2014;3:146\u201355. https:\/\/doi.org\/10.1016\/j.vhri.2014.04.008.","journal-title":"Value Health Reg Issue"},{"issue":"2","key":"86_CR60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/21645515.2015.1067351","volume":"12","author":"DBC Wu","year":"2016","unstructured":"Wu DBC, Roberts C, Lee VWY, Hong LW, Tan KK, Mak V, et al. Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccines Immunotherapeutics. 2016;12(2):403\u201316. https:\/\/doi.org\/10.1080\/21645515.2015.1067351.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"32","key":"86_CR61","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1016\/j.vaccine.2019.06.015","volume":"37","author":"P Dilokthornsakul","year":"2019","unstructured":"Dilokthornsakul P, Kengkla K, Saokaew S, Permsuwan U, Techasaensiri C, Chotpitayasunondh T, et al. An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand. Vaccine. 2019;37(32):4551\u201360. https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.015.","journal-title":"Vaccine"},{"key":"86_CR62","doi-asserted-by":"publisher","unstructured":"Rahman NA, Teng CL, Sivasampu S. Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. BMC Infect Dis. 2016;16(1):208. https:\/\/doi.org\/10.1186\/s12879-016-1530-2.","DOI":"10.1186\/s12879-016-1530-2"},{"issue":"3","key":"86_CR63","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","volume":"15","author":"M Moore","year":"2015","unstructured":"Moore M, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett N, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(14)71081-3.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"86_CR64","first-page":"134","volume":"71","author":"HC McNeil","year":"2016","unstructured":"McNeil HC, Clarke SC. Serotype prevalence of Streptococcus pneumoniae in Malaysia - the need for carriage studies. Med J Malays. 2016;71(3):134\u20138.","journal-title":"Med J Malays"},{"issue":"1","key":"86_CR65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","volume":"32","author":"C Satzke","year":"2013","unstructured":"Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization pneumococcal carriage working group. Vaccine. 2013;32(1):165\u201379. https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.062.","journal-title":"Vaccine"},{"issue":"43","key":"86_CR66","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1016\/j.vaccine.2019.08.073","volume":"37","author":"J Chan","year":"2019","unstructured":"Chan J, Nguyen CD, Dunne EM, Mulholland EK, Mungun T, Pomat WS, et al. Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries. Vaccine. 2019;37(43):6299\u2013309. https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.073.","journal-title":"Vaccine"},{"key":"86_CR67","doi-asserted-by":"publisher","unstructured":"Coughtrie AL, Jefferies JM, Cleary D, Doncaster CP, Faust S, Kraaijeveld A, et al. Microbial epidemiology and carriage studies for the evaluation of vaccines. J Med Microbiol. 2019;68(10):1408-18. https:\/\/doi.org\/10.1099\/jmm.0.001046.","DOI":"10.1099\/jmm.0.001046"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-021-00086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-021-00086-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-021-00086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T23:08:20Z","timestamp":1621897700000},"score":1,"resource":{"primary":{"URL":"https:\/\/pneumonia.biomedcentral.com\/articles\/10.1186\/s41479-021-00086-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1186\/s41479-021-00086-7","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SCC acts as principal investigator on studies conducted on behalf of University Hospital Southampton NHS Foundation Trust and the University of Southampton that are sponsored by vaccine manufacturers but receives no personal payments. SCC has received financial assistance from vaccine manufacturers to attend conferences. SCC has participated in advisory boards for vaccine manufacturers but receives no personal payments. DWC was a post-doctoral researcher on projects funded by Pfizer and GSK between April 2014 and 20th October 2017. All other authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}